Phathom Pharmaceuticals (PHAT) is scheduled to announce Q3 earnings results on Thursday, October 29th, before market open. – The consensus EPS estimate is -$0.14 (+6.7% Y/Y), and the consensus revenue estimate is $84.82M (+71.4% Y/Y). – Over the last 2 years, PHAT
Phathom Pharmaceuticals Q3 2026 Earnings Preview
Phathom Pharmaceuticals (PHAT) is scheduled to announce Q3 earnings results on Thursday, October 29th, before market open. - The consensus EPS estimate is -$0.14 (+6.7% Y/Y), and the consensus revenue estimate is $84.82M (+71.4% Y/Y). - Over the last 2 years, PHAT